Targeting BCL6 in diffuse large B-cell lymphoma: what does this mean for the future treatment? (Q39358270)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 2013

edit

Language	Label	Description	Also known as
English	Targeting BCL6 in diffuse large B-cell lymphoma: what does this mean for the future treatment?	scientific article published on August 2013

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

4083750

retrieved

11 September 2017

editorial

0 references

title

Targeting BCL6 in diffuse large B-cell lymphoma: what does this mean for the future treatment? (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

4083750

retrieved

11 September 2017

main subject

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

author

Leandro Cerchietti

object named as

Leandro Cerchietti

series ordinal

1

0 references

author name string

Ari Melnick

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

4083750

retrieved

11 September 2017

publication date

1 August 2013

1 reference

stated in

Europe PubMed Central

PMC publication ID

4083750

retrieved

11 September 2017

published in

Expert Review of Hematology

1 reference

stated in

Europe PubMed Central

PMC publication ID

4083750

retrieved

11 September 2017

volume

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

4083750

retrieved

11 September 2017

issue

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

4083750

retrieved

11 September 2017

page(s)

343-345

1 reference

stated in

Europe PubMed Central

PMC publication ID

4083750

retrieved

11 September 2017

cites work

A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

11 September 2017

Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated by distinct biochemical mechanisms

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

11 September 2017

Roles of BCL6 in normal and transformed germinal center B cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

11 September 2017

BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

11 September 2017

Aggressive lymphomas

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

11 September 2017

A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

11 September 2017

Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

11 September 2017

BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

11 September 2017

The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

11 September 2017

A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

11 September 2017

Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

11 September 2017

Sequential transcription factor targeting for diffuse large B-cell lymphomas

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

11 September 2017

Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

11 September 2017

The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

11 September 2017

Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

14 September 2017

The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

17 June 2018

Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083750

retrieved

21 August 2018

Identifiers

DOI

10.1586/17474086.2013.826928

1 reference

stated in

Europe PubMed Central

PMC publication ID

4083750

retrieved

11 September 2017

PMC publication ID

4083750

1 reference

stated in

Europe PubMed Central

PMC publication ID

4083750

retrieved

11 September 2017

PubMed publication ID

23991920

1 reference

stated in

Europe PubMed Central

PMC publication ID

4083750

retrieved

11 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39358270&oldid=1527279229"